» Articles » PMID: 19834493

Disruption of PPARgamma Signaling Results in Mouse Prostatic Intraepithelial Neoplasia Involving Active Autophagy

Overview
Specialty Cell Biology
Date 2009 Oct 17
PMID 19834493
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxisome proliferator-activated receptor-gamma (PPARgamma) regulates the interface between cellular lipid metabolism, redox status and organelle differentiation. Conditional prostatic epithelial knockout of PPARgamma in mice resulted in focal hyperplasia which developed into mouse prostatic intraepithelial neoplasia (mPIN). The grade of PIN became more severe with time. Electron microscopy (EM) showed accumulated secondary lysosomes containing cellular organelles and debris suggestive of autophagy. Consistent with this analysis the autophagy marker LC-3 was found to be upregulated in areas of PIN in PPARgamma KO tissues. We selectively knocked down PPARgamma2 isoform in wild-type mouse prostatic epithelial cells and examined the consequences of this in a tissue recombination model. Histopathologically grafted tissues resembled the conditional PPARgamma KO mouse prostates. EM studies of PPARgamma- and PPARgamma2-deficient epithelial cells in vitro were suggestive of autophagy, consistent with the prostatic tissue analysis. This was confirmed by examining expression of beclin-1 and LC-3. Gene expression profiling in PPARgamma-/gamma2-deficient cells indicated a major dysregulation of cell cycle control and metabolic signaling networks related to peroxisomal and lysosomal maturation, lipid oxidation and degradation. The putative autophagic phenotypes of PPARgamma-deficient cells could be rescued by re-expression of either gamma1 or gamma2 isoform. We conclude that disruption of PPARgamma signaling results in autophagy and oxidative stress during mPIN pathogenesis.

Citing Articles

Neuronal fatty acid-binding protein enhances autophagy and suppresses amyloid-β pathology in a Drosophila model of Alzheimer's disease.

Jang S, Choi B, Lim C, Kim M, Lee J, Lee H PLoS Genet. 2024; 20(11):e1011475.

PMID: 39561115 PMC: 11575808. DOI: 10.1371/journal.pgen.1011475.


Asiatic acid mitigates testosterone-induced benign prostatic hyperplasia in rats via activation of PPAR-γ.

Kamal H, Almutairi B, Abdel-Naim A Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1991-2001.

PMID: 39222244 DOI: 10.1007/s00210-024-03405-z.


Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells.

Olokpa E, Mandape S, Pratap S, Stewart L BMC Cancer. 2022; 22(1):1025.

PMID: 36175875 PMC: 9520831. DOI: 10.1186/s12885-022-10115-3.


PPARγ2 functions as a tumor suppressor in a translational mouse model of human prostate cancer.

Dong F, Liu D, Lu T, Li F, Zhang C, E Q Asian J Androl. 2021; 24(1):90-96.

PMID: 34213488 PMC: 8788601. DOI: 10.4103/aja.aja_51_21.


Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate.

Olokpa E, Moss P, Stewart L PPAR Res. 2017; 2017:9456020.

PMID: 29181019 PMC: 5664321. DOI: 10.1155/2017/9456020.


References
1.
Sarraf P, Mueller E, Jones D, KING F, DeAngelo D, Partridge J . Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med. 1998; 4(9):1046-52. DOI: 10.1038/2030. View

2.
Shappell S, Boeglin W, Olson S, Kasper S, Brash A . 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol. 1999; 155(1):235-45. PMC: 1866677. DOI: 10.1016/S0002-9440(10)65117-6. View

3.
Chang C, Liao J, Huang W, Lee H . Lysophosphatidic acid inhibits serum deprivation-induced autophagy in human prostate cancer PC-3 cells. Autophagy. 2007; 3(3):268-70. DOI: 10.4161/auto.3909. View

4.
Jiang M, Shappell S, Hayward S . Approaches to understanding the importance and clinical implications of peroxisome proliferator-activated receptor gamma (PPARgamma) signaling in prostate cancer. J Cell Biochem. 2004; 91(3):513-27. DOI: 10.1002/jcb.10770. View

5.
Kirschenbaum A, Liotta D, Yao S, Liu X, Klausner A, Unger P . Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts. J Clin Endocrinol Metab. 2000; 85(9):3436-41. DOI: 10.1210/jcem.85.9.6780. View